TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS
Abstract
To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients.
Key facts
- NIH application ID
- 10186436
- Project number
- 272201600015C-P00005-9999-1
- Recipient
- FRED HUTCHINSON CANCER RESEARCH CENTER
- Principal Investigator
- MICHAEL BOECKH
- Activity code
- N01
- Funding institute
- NIH
- Fiscal year
- 2020
- Award amount
- $1,476,477
- Award type
- —
- Project period
- 2016-07-01 → 2022-06-15